CD19 and breast cancer: The reduction in HLA-DR observed in breast cancer patients compared to healthy controls was not correlated to sex or age and was exclusive for monocytes as CD19+ B lymphocytes displayed normal or only slightly reduced levels of HLA-DR (data not shown).